NeoVize
NeoVize is the largest private eye clinic group in the Czech-Slovak region, operating self-owned facilities across three countries to provide laser refractive surgery, premium cataract, retina, keratoconus, and AI-supported diabetic retinopathy screening to self-pay and publicly insured patients.
- Company typePrivate
- Founded2008
- HeadquartersPraha, Czechia
- Headcount251–500
- GTM typeB2C
- OfferingServices
What NeoVize does
NeoVize s.r.o. is the operating entity of the largest Czech-Slovak-Polish private eye clinic group, founded in 2008 by CEO Petr Kocian. The group operates three full-service surgical eye clinics (Brno, Prague, Český Těšín) plus multiple satellite eye ambulances (Prague Kamýk, Brno Koliště, Újezd u Brna) and in-house optical retail, performing more than 300,000 eye operations cumulatively since inception and conducting over 15,000 eye examinations per year. Service lines span the full ophthalmology spectrum: laser refractive surgery (NeoSMILE PRO® using ReLEx SMILE and NeoLASIK HD® using femtoLASIK on the Carl Zeiss VISUMAX 800 and MEL 90 platforms, plus PRESBYOND® and HyperSMILE for presbyopia/hypermetropia), cataract surgery using ultrasound and the Alcon LenSx femtosecond laser, premium intraocular lens implantation (Alcon PanOptix, Zeiss AT LISA Tri trifocal and EDoF Vivity), phakic IOL (STAAR EVO ICL®), refractive lens exchange (RLE) and PRELEX, retina and vitreous surgery (Constellation PPV), anti-VEGF biological therapy, keratoconus treatment (Keraring, CCL/CXL cross-linking), and AI-powered diabetic retinopathy screening via the co-developed Aireen system.
The business model is a hybrid of public-payer reimbursement and private-pay all-inclusive packages. Standard cataract surgery and certain diagnostics are reimbursed through contracts with all six major Czech public health insurers (VZP, VoZP, ČPZP, OZP, ZPMV, RBP). All premium/elective procedures — laser refractive surgery, premium trifocal/EDoF IOL upgrades over the standard monofocal, EVO ICL, PRELEX, and self-pay examinations — are out-of-pocket. Package pricing is published and transparent (e.g., 22,500 CZK per eye for NeoLASIK HD® or 23,700 CZK per eye for premium cataract with trifocal IOL), and a proprietary 0% interest installment plan over 12 months removes the upfront cost barrier for elective surgery. Distribution is exclusively through owned-and-operated clinic facilities; patients are acquired through direct-to-consumer channels (Google Business Profile, organic SEO, Facebook/Instagram/YouTube, patient testimonials, and a multilingual website in CZ/SK/PL/EN/DE/IT targeting Western European medical tourism). The group also operates adjacent specialty clinics — DIAvize (diabetes/endocrinology), UroKlinikum and UroVize (urology) — under the same founder, and sister brands NeoVízia (Slovakia) and NeoVize.pl (Poland). Certifications include ISO 9001:2015 and Czech Ministry of Health facility accreditation.
NeoVize firmographics
Firmographics- Name
- NeoVize
- Legal name
- NeoVize s.r.o.
- Website
- https://neovize.cz
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- NeoVize is the largest private eye clinic group in the Czech-Slovak region, operating self-owned facilities across three countries to provide laser refractive surgery, premium cataract, retina, keratoconus, and AI-supported diabetic retinopathy screening to self-pay and publicly insured patients.
- Ownership category
- akta.pro rank
NeoVize industry classification
Industry- Product category
- Ophthalmology and Refractive Surgery
- NAICS
- Offices of Optometrists (62132)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)
- akta.pro secondary industries
- Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF), Retina & Vitreous Specialists (HLAKAKAE), Ophthalmology Surgery Centers (HLAFAIAF)
Keywords
Where NeoVize is headquartered
LocationHeadquarters
- HQ city
- Praha
- HQ country
- Czechia
- HQ region
- Europe
Offices6 records
Markets served
NeoVize business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Private-pay elective eye surgery: Laser eye surgery (NeoSMILE PRO, NeoLASIK HD, PRK/LASEK), premium cataract surgery with trifocal/EDoF lenses, presbyopia surgery (PRELEX), phakic IOL implantation (EVO ICL), and other refractive procedures are paid directly by patients. Cataract surgery with standard monofocal IOLs is covered by public health insurance. Premium lens upgrades and all laser/refractive procedures are entirely out-of-pocket.
- Public health insurance reimbursement: Standard cataract surgery and certain diagnostic examinations are reimbursed through Czech public health insurance companies (Všeobecná zdravotní pojišťovna, Vojenská, ČPZP, OZP, ZPMV, RBP). NeoVize is contracted with multiple insurance funds.
- Installment financing (splátkový program): A proprietary 0% interest installment plan allowing patients to spread the cost of laser and intraocular operations over 12 months with a 10,000 CZK deposit. Revenue is recognized at the full procedure price; financing is provided internally or through a partner financial institution.
- Out-of-pocket examination and screening fees: Self-paying patients (samoplátci) pay for comprehensive eye exams, specialized diagnostics (OCT, pachymetry, Pentacam, tear film analysis), and diabetic retinopathy screening (Aireen, free for diabetics). Price lists range from 300–3,500 CZK depending on service.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | NeoLASIK HD® laser surgery — all-inclusive package for one eye |
| One time/ perpetual license | Pay-as-you-go | Premium cataract surgery with trifocal IOL — per eye |
| Unit Pricing | Pay-as-you-go | Self-pay examination fees at Újezd u Brna ambulance |
| Other | Multi-year contract | Doživotní záruka (lifetime warranty) — included in NeoSMILE PRO and NeoLASIK HD packages |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
NeoVize product offering
Product offeringCore offering
NeoVize is a private Czech eye clinic network operating since 2008 that provides comprehensive ophthalmology services, including laser refractive surgery (NeoSMILE PRO, NeoLASIK HD, PRESBYOND), cataract surgery (standard and LenSx laser-assisted), premium intraocular lens implantation (PanOptix, AT LISA Tri, EVO ICL), presbyopia correction (PRELEX, RLE), retina and vitreous surgery (PPV, anti-VEGF), keratoconus treatment (Keraring, CCL/CXL), and AI-powered diabetic retinopathy screening (Aireen). Services are delivered through owned clinics across the Czech Republic with sister clinics in Slovakia and Poland.
Product overview
NeoVize is a Czech eye clinic network (Oční klinika NeoVize) operating since 2008, with locations in Prague, Brno, and Český Těšín, plus satellite eye ambulances in Prague Kamýk, Brno Koliště, and Újezd u Brna. The group is the largest Czech-Slovak eye clinic network, performing hundreds of thousands of total eye operations. NeoVize operates as a multi-service ophthalmology practice offering: (1) Laser refractive surgery (NeoSMILE PRO® using ReLEx SMILE/VISUMAX 800, NeoLASIK HD® using femtoLASIK, PRESBYOND®, and HyperSMILE); (2) Cataract surgery (standard ultrasound and LenSx laser-assisted); (3) Premium intraocular lenses (trifocal PanOptix, AT LISA Tri, and EDoF Vivity lenses by Alcon and Carl Zeiss); (4) Phakic intraocular lenses (EVO ICL® by STAAR Surgical) for younger patients; (5) Refractive lens exchange (RLE/CLE) and PRELEX for presbyopia; (6) Retina and vitreous surgery (PPV, anti-VEGF biological therapy); (7) Keratoconus treatment (Keraring ICRS and CCL/CXL); (8) AI-powered diabetic retinopathy screening (Aireen); (9) Comprehensive eye examinations; and (10) Retail eye optics. The portfolio is unified under the NeoVize brand with all-inclusive treatment packages that include pre-operative examination, surgery, and post-operative care. Lifetime guarantees are offered on laser procedures, and interest-free installment financing is available.
Differentiator
Problem solved
Functional benefit
Brands
- NeoSMILE 3D®: Registered trademark for ReLEx SMILE laser eye surgery procedures
- NeoLASIK HD®
Products and services
- NeoSMILE PRO® All-inclusive laser eye surgery package using the ReLEx SMILE method with the VISUMAX 800 femtosecond laser. A minimally invasive, precise and painless procedure that separates a thin layer of tissue inside the cornea without disrupting corneal strength and stability, suitable for myopia, hyperopia, and astigmatism. Includes lifetime warranty.
- NeoLASIK HD® All-inclusive femtoLASIK laser eye surgery package using VISUMAX 800 femtosecond laser and MEL 90 excimer laser. Creates a protective corneal flap with the femtosecond laser and vaporizes diopter layers with the excimer laser; rapid healing. Includes lifetime warranty.
- PRESBYOND® Laser-based presbyopia treatment using a blend zone technique that enables patients over 40 to see clearly at near, intermediate and distance without glasses.
- HyperSMILE SMILE-based laser procedure for correction of hypermetropia (farsightedness) and astigmatism, performed at the NeoVízia clinic in Bratislava.
- Cataract Surgery (Šedý zákal) Cataract removal surgery performed either with ultrasound or with the LenSx femtosecond laser. The clouded natural lens is removed and replaced with an artificial intraocular lens. Covered by Czech public health insurance with standard monofocal IOLs.
- LenSx Laser Cataract Surgery Laser-assisted cataract surgery using the Alcon LenSx femtosecond laser, a knife-free technique for precise corneal incisions replacing manual surgical blades.
- Premium Trifocal / Multifocal Intraocular Lens Implantation (PanOptix, AT LISA Tri) Premium intraocular lenses (IOL) used in cataract surgery and PRELEX. Trifocal lenses (Alcon PanOptix, Zeiss AT LISA Tri) improve vision at near, intermediate and distance; EDoF lenses provide sharp distance and intermediate vision.
- EVO ICL® (Implantable Collamer Lens) Phakic intraocular contact lens (ICL) implanted behind the iris for correction of low, moderate and high myopia, hyperopia and astigmatism. Suitable for patients under 40 years of age. Manufactured by STAAR Surgical, CE and FDA approved.
- PRELEX (Presbyopic Lens Exchange) Refractive lens exchange combined with multifocal intraocular lens implantation for patients over 40, eliminating the need for reading glasses by enabling near and distance vision without eyewear.
- RLE (Refractive Lens Exchange / CLE) Refractive lens exchange for patients over 40 with refractive errors beyond the range of laser procedures. Replaces the natural lens with an artificial intraocular lens, reducing risk of future cataract and glaucoma.
- Retina and Vitreous Treatment (PPV) Pars plana vitrectomy (PPV) using the Alcon Constellation system for treatment of retinal and vitreous diseases, including 23G and 25G sutureless techniques, laser retina treatment, cryopexy and biological therapy.
- Biological Therapy / Anti-VEGF Injections Intravitreal injections of anti-VEGF preparations (e.g., bevacizumab) for wet age-related macular degeneration, diabetic macular edema, myopic macular degeneration and retinal vein occlusions, administered in outpatient settings.
- Keraring (ICRS - Intrastromal Corneal Ring Segments) Implantation of semi-annular intrastromal corneal ring segments (Kerarings) made of PMMA to flatten and stabilize keratoconic cornea, with tunnels created using the VisuMax femtosecond laser.
- CCL / CXL (Corneal Cross Linking) Collagen Cross Linking treatment for keratoconus. Riboflavin (vitamin B2) is applied to the cornea followed by UV light irradiation, creating cross-links between collagen fibers to stabilize and strengthen the cornea and halt further bulging.
- Aireen AI Diabetic Retinopathy Screening AI-based screening system that analyzes retinal photographs to detect the presence of diabetic retinopathy. Co-developed with leading Czech ophthalmologists, diabetologists and academic institutions. Free screening available at NeoVize clinics for diabetics.
Quantifiable outcome
- 94% of patients report positive life changes after the procedure
- +5 more outcomes
Companies that use NeoVize
Customer profileNamed customers7 records
Segments6 records
Ideal customer profiles6 records
NeoVize technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature7 records
NeoVize partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- Carl Zeiss MediteccorePrimary technology provider for laser surgical systems. NeoVize uses the VISUMAX 800 femtosecond laser and MEL 90 excimer laser from Carl Zeiss for all laser refractive procedures. Zeiss surgical microscopes are also used in the operating theatres. This partnership is fundamental to NeoVize's core laser surgery offering.
- AlconcoreProvider of the LenSx femtosecond laser (for bladeless cataract surgery), the Constellation vitrectomy system (for retina surgery with integrated endolaser), and premium intraocular lenses including PanOptix trifocal and AT LISA Tri lenses. Alcon IOLs are used in cataract, PRELEX, and RLE procedures. All Alcon products are approved by the European Union and the US FDA.
- STAAR SurgicalcoreSwiss manufacturer of EVO ICL (EVO Viva) phakic intraocular contact lenses used for correction of high myopia, hyperopia, and astigmatism. NeoVize uses exclusively premium EVO ICL lenses. The EVO ICL is approved by the European Union and US FDA.
- Aireen (AI diabetic retinopathy screening)coreAI-powered diabetic retinopathy screening system developed in collaboration with leading Czech ophthalmologists, diabetologists, and academic institutions including the Eye Clinic of 1st Faculty of Medicine of Charles University and Central Military Hospital, and Czech University of Life Sciences Prague. NeoVize participated in the development of Aireen. The system is also supported by Intel Partner Alliance, Microsoft for Startups, and Vodafone. Aireen enables rapid, painless, AI-evaluated retinal screening.
- NeoVízia (Slovakia)coreSister eye clinic brand in Slovakia (Bratislava and Poprad) operated under the NeoVize Group umbrella. Enables cross-border referrals and serves Slovak-speaking patients with the same quality standards and technology. Referenced on the Czech website as a related partner.
- NeoVize.pl (Poland)minorPolish sister eye clinic brand under the NeoVize Group. Referenced as a related partner on the Czech website.
- Dětské oční centrum KukátkominorChildren's eye center referral partner. NeoVize refers pediatric patients requiring strabismus (squint) surgery and amblyopia (lazy eye) treatment to this specialized children's clinic.
- Oční Centrum PrahaminorPartner eye clinic in Prague referenced on the NeoVize website footer. Nature of partnership not detailed.
- Praga MedicaminorMedical tourism partner facilitating international patient referrals to NeoVize clinics. Listed as a related partner on the website.
- FertilityPort PragueminorFertility and reproductive health clinic partner under the broader NeoVize Group healthcare ecosystem. Listed as a related partner on the website.
- All major Czech public health insurerscoreContracted health insurance providers covering standard procedures (cataract surgery, eye examinations). Includes Všeobecná zdravotní pojišťovna ČR (111), Vojenská zdravotní pojišťovna (201), Česká průmyslová zdravotní pojišťovna (205), Oborová zdravotní pojišťovna (207), Zdravotní pojišťovna Ministerstva vnitra ČR (211), Revírní bratrská pokladna (213). Premium/advanced treatments are private-pay.
Scale indicators10 records
Recent moves14 records
Expansion highlights6 records
NeoVize competitors and assessment
Company assessmentDirect peers
- Optegra: UK-headquartered private eye hospital group with clinics in the UK, Czech Republic, Poland, and Germany. Directly comparable multi-country European ophthalmology chain offering cataract, refractive, and retina services to private-pay patients.
- EuroEyes: German-based premium laser eye surgery chain with clinics across Germany, the UK, Denmark, and China. Directly comparable as a premium private refractive and lens surgery operator using Carl Zeiss and other tier-1 lasers, and one of the few publicly listed European eye-surgery comparables.
- TLC Laser Eye Centers: Largest North American provider of laser vision correction with dozens of clinics. Comparable as a multi-clinic premium refractive-surgery chain relying on tier-1 femtosecond lasers and offering all-inclusive pricing — a useful benchmark for unit economics even though geographically distant.
- Memira / Eye Clinic Group (Nordic): Nordic private eye clinic chain operating across Sweden, Norway, Denmark, and Germany. Comparable premium refractive and cataract provider using tier-1 laser OEMs and offering installment financing — one of the original European eye-surgery consolidators.
- Lexum: Czech private eye clinic chain founded by the same Petr Kocian before he started NeoVize in 2008. Directly comparable as a Central European premium ophthalmology provider with overlapping laser cataract and refractive surgery offerings and a shared clinical pedigree.
- Optimax: UK private laser eye surgery specialist with a national clinic network offering LASIK, LASEK, and lens replacement. Comparable as a long-established European private refractive chain with similar all-inclusive pricing and 0% financing positioning.
- Care Vision (Care-Vision Germany): German private eye clinic network offering laser vision correction, lens surgery, and cataract treatment. Closely comparable multi-clinic European private-pay ophthalmology operator competing in the same premium refractive segment.
Broad incumbents
- Fielmann: Europe's largest optical retail chain with attached eye clinics and growing refractive surgery offerings. Comparable as a vertically integrated vision-care provider combining retail optics with clinical ophthalmology, representing both a potential customer pathway and a competitive adjacent model.
- Smile Eyes (Sanoptis group): German ophthalmology platform operating the Smile Eyes and other clinic brands. Comparable as a PE-backed European eye clinic consolidator that has used acquisition roll-ups to scale refractive and cataract services — a relevant blueprint for any future NeoVize expansion.
Regional players
- Oční klinika FN Hradec Králové: Hospital-based ophthalmology department in the Czech Republic performing cataract and retina surgery. Relevant regional comparator for procedure volume, public reimbursement economics, and competition for Czech surgical talent.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
NeoVize social profiles
Digital presenceNeoVize compliance and trust
Trust signalCompliance2 records
NeoVize financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeoVize leadership team
Management profileNumber of profiles
Profiles8 records
NeoVize subsidiaries and ownership
Company hierarchySubsidiaries7 records
NeoVize funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeoVize M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeoVize
What does NeoVize do?
NeoVize is a private Czech eye clinic network operating since 2008 that provides comprehensive ophthalmology services, including laser refractive surgery (NeoSMILE PRO, NeoLASIK HD, PRESBYOND), cataract surgery (standard and LenSx laser-assisted), premium intraocular lens implantation (PanOptix, AT LISA Tri, EVO ICL), presbyopia correction (PRELEX, RLE), retina and vitreous surgery (PPV, anti-VEGF), keratoconus treatment (Keraring, CCL/CXL), and AI-powered diabetic retinopathy screening (Aireen). Services are delivered through owned clinics across the Czech Republic with sister clinics in Slovakia and Poland.
Is NeoVize a public or private company?
NeoVize is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NeoVize founded?
NeoVize was founded in 2008. It employs 251 to 500 people.
Where is NeoVize based?
NeoVize is headquartered in Praha, Czechia, in the Europe region.
How does NeoVize make money?
Four revenue lines are on record. Private-pay elective eye surgery is the primary driver. The others are public health insurance reimbursement, installment financing (splátkový program) and out-of-pocket examination and screening fees.
Who are NeoVize's main competitors?
Direct peers on record are Optegra, EuroEyes, TLC Laser Eye Centers, Memira / Eye Clinic Group (Nordic), Lexum, Optimax and Care Vision (Care-Vision Germany). Broad incumbents are Fielmann and Smile Eyes (Sanoptis group). Oční klinika FN Hradec Králové is listed as a regional player.
Does NeoVize have an API?
No public API is recorded for NeoVize.
What industry is NeoVize in?
NeoVize's product category is Ophthalmology and Refractive Surgery. Its primary akta.pro industry code is HLAKAKAC, Ophthalmology Clinics (Medical & Surgical Eye Care), with a secondary code of HLAKAKAF, Cornea, External Disease & Refractive Surgery (LASIK/PRK). Its NAICS code is 62132 and its SIC code is 8011.